UNITED COMMUNITY BANKS/GA
UCBNYSETrading Snapshot
- Day Range
- $36.12 β $36.76
- 52-Week Range
- $28.65 β $37.45
- Volume (shares)
- 1,178,219
- Avg Volume (shares)
- β
- Shares Outstanding
- 119.8M
- Next Earnings
- 2027-01-12
Fundamentals Snapshot
- Annual Revenue
- $1.54B
- Last Q Revenue
- $99M
- P/E Ratio
- 30.7
- P/S Ratio
- 3.5x
- EPS (TTM)
- $1.22
- Dividend Yield
- 2.76%
- Dilution (1yr)
- +1.6%
UNITED COMMUNITY BANKS/GA
UCBAbout UNITED COMMUNITY BANKS/GA
United Community Banks, Inc. functions as the parent entity for United Community Bank, through which it delivers a comprehensive array of financial solutions. These offerings cater to a diverse clientele, encompassing commercial enterprises, individual consumers, governmental bodies, educational institutions, and entities within the energy, healthcare, and real estate industries. Its core banking activities include accepting various deposit accounts, such as checking, savings, and money market options. The institution extends a broad spectrum of lending products, including real estate, consumer, and commercial loans. These are provided to individuals, small and mid-sized businesses, and non-profit organizations, encompassing both secured and unsecured options, as well as specialized mortgage financing. Furthermore, it originates loans partially backed by government initiatives like the Small Business Administration (SBA) and U.S. Department of Agriculture (USDA) programs. Beyond traditional banking, United Community Banks offers robust wealth management services, covering financial planning, bespoke portfolio management, and expert investment guidance. This is complemented by trust services for fiduciary asset administration, non-deposit investment alternatives, and a suite of insurance products, including life, long-term care, and tax-deferred annuities. The company also strategically invests its own capital in a range of securities, including residential and commercial mortgage-backed securities, asset-backed securities, U.S. Treasury and agency obligations, and municipal bonds. Additionally, the firm provides an extensive suite of supplementary financial tools, such as treasury management, credit and debit card services, diverse payment and commerce solutions, equipment financing, and dedicated investment advisory and brokerage services. It also facilitates reinsurance for property contracts, operates as an insurance agency, and offers specialized services like payment processing, merchant services, wire transfers, and private banking. Established in 1950, United Community Banks, Inc. maintains its corporate headquarters in Blairsville, Georgia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Are You Looking for a Top Momentum Pick? Why United Community Banks (UCB) is a Great Choice
Does United Community Banks (UCB) have what it takes to be a top stock pick for momentum investors? Let's find out.

United Community Banks: 3 Key Takeaways for Long-Term Investors
Operating earnings reached $0.77 per share in the third quarter. Core annualized loan growth reached 10% excluding Navitas and Peach State.

United Community Banks (UCB) Upgraded to Strong Buy: Here's What You Should Know
United Community Banks (UCB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Income Stocks to Buy for October 22nd
BBCP, ATLO and UCB made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 22, 2026.

New Strong Buy Stocks for October 22nd
BBCP, UCB, TGS, STX and IMUX have been added to the Zacks Rank #1 (Strong Buy) List on October 22, 2026.

UCB Shares Jump After Demand for Immunology Drug Bimzelx Boosts Outlook
Shares were up 13%βerasing losses in the year to dateβafter the company raised its annual guidance for the second time this year, citing strong U.S. demand for its blockbuster drug.